Page last updated: 2024-08-21

isoxazoles and Tobacco Use Disorder

isoxazoles has been researched along with Tobacco Use Disorder in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Akinola, LS; Alkhlaif, Y; Bautista, MR; Carper, M; Chen, YC; Damaj, MI; Fowler, CD; Garai, S; Hamouda, AK; Jackson, A; Thakur, GA; Toma, WB1

Other Studies

1 other study(ies) available for isoxazoles and Tobacco Use Disorder

ArticleYear
Potentiation of (α4)2(β2)3, but not (α4)3(β2)2, nicotinic acetylcholine receptors reduces nicotine self-administration and withdrawal symptoms.
    Neuropharmacology, 2021, 06-01, Volume: 190

    Topics: Allosteric Regulation; Animals; Behavior, Animal; Hydrocarbons, Brominated; Indole Alkaloids; Isoxazoles; Mice; Nicotine; Nicotinic Agonists; Protein Isoforms; Pyrazoles; Receptors, Nicotinic; Self Administration; Substance Withdrawal Syndrome; Tobacco Use Disorder

2021